4DMedical Limited (ASX:4DX)
Australia · Delayed Price · Currency is AUD 5.70
+0.06 (1.06%)
Apr 7, 2026, 4:13 PM AEST
4DMedical Market Cap
4DMedical has a market cap or net worth of 3.32 billion as of April 7, 2026. Its market cap has increased by 1,948.21% in one year.
Market Cap
3.32B
Enterprise Value
3.28B
Revenue
5.81M
Ranking
n/a
PE Ratio
n/a
Stock Price
5.70
Market Cap Chart
Since August 7, 2020, 4DMedical's market cap has increased from 420.97M to 3.32B, an increase of 689.60%. That is a compound annual growth rate of 44.11%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 2, 2026 | 3.32B | 58.47% |
| Dec 31, 2025 | 2.10B | 961.67% |
| Dec 31, 2024 | 197.57M | -29.31% |
| Dec 29, 2023 | 279.48M | 125.82% |
| Dec 30, 2022 | 123.76M | -68.87% |
| Dec 31, 2021 | 397.56M | -38.21% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Aug 7, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Cochlear | 11.27B |
| Anteris Technologies Global | 734.10M |
| PolyNovo | 645.94M |
| Aroa Biosurgery | 200.38M |
| Lumos Diagnostics Holdings | 168.57M |
| EMVision Medical Devices | 148.70M |
| Epiminder | 133.60M |
| SomnoMed | 129.26M |